Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study
- 26 July 2005
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 131 (9) , 568-574
- https://doi.org/10.1007/s00432-005-0675-y
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-studyInvestigational New Drugs, 2005
- Randomized phase III study of epirubicin (E) versus gemcitabine (G) chemotherapy in elderly females with metastatic breast cancer (MBC)European Journal Of Cancer, 2002
- Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumorsAnti-Cancer Drugs, 2001
- Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancerThe Breast, 2000
- Prolonged infusion of gemcitabine in stage IV breast cancerAnti-Cancer Drugs, 1999
- Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancerAnti-Cancer Drugs, 1999
- Safety profile of gemcitabineAnti-Cancer Drugs, 1995
- Phase II Trial of Weekly IV Vinorelbine as a Single Agent in First-Line Advanced Breast Cancer ChemotherapyAmerican Journal of Clinical Oncology, 1995
- Saturation of 2?, 2?-difluorodeoxycytidine 5?-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabineCancer Chemotherapy and Pharmacology, 1991
- Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubulesInternational Journal of Cancer, 1990